Tourmaline Bio FY2024 EPS Forecast Raised by Leerink Partnrs
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Investment analysts at Leerink Partnrs increased their FY2024 earnings per share (EPS) estimates for Tourmaline Bio in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now expects that the company will post earnings of ($2.83) per share for the year, up from […]
![Tourmaline Bio FY2024 EPS Forecast Raised by Leerink Partnrs](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tourmaline-bio-inc-logo-1200x675.jpg?v=20241212125633&w=240&h=240&zc=2)